Popular Articles

Unique Collaboration Between TB Alliance And Tibotec To Accelerate Tuberculosis Drug Development
A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec Inc., (Tibotec), a global pharmaceutical company, has been announced at the Pacific Health Summit in response to the urgent need to accelerate the discovery and development of new drugs to fight tuberculosis (TB).
pharmacy online
Breast Cancer Risk Signalled By Wet Ear Wax And Unpleasant Body Odors
If having malodorous armpits (called osmidrosis) and goopy earwax isn"t bad enough, a discovery by Japanese scientists may add a more serious problem for women facing these cosmetic calamities. That"s because they"ve found that a gene responsible for breast cancer causes these physical symptoms. The report describing this finding is featured on the cover of The FASEB Journal"s June 2009 print issue, and should arm physicians with another clue for detecting breast cancer risk.
News of the day
Merck KGaA Considers Appealing CHMP Opinion On Erbitux Treatment For Non-Small Cell Lung Cancer
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted a negative opinion for the use of Erbitux® (cetuximab) in combination with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, advanced or metastatic non-small cell lung cancer (NSCLC). Merck KGaA is evaluating potential appeal options requesting that the CHMP re-examine data demonstrating clinical relevant benefits to patients.
Cardiovascular

Ghana Seeks To Eliminate Malaria, Health Minister Says

In October, Ghana"s Ministry of Health plans to begin a national program to eliminate malaria with the goal of being the first country in Africa to eradicate the disease, George Sipa-Adjah Yankey, the minister of health, said recently at the 74th Annual Conference of the Pharmaceutical Society of Ghana in Accra, Ghana, GNA/Homepage Ghana reports. Yankey cited the looming threat of the malaria parasite"s resistance to artemisinin therapy (8/3). According to Yankey, the government spends more than $760 million annually on malaria treatments, Ghanadot.com reports. "It is social justice if we strive to relieve the poor of over 35 percent of their income which would otherwise be spent on malaria. And it is morally right if we work to save those children who loose the battle with malaria every minute," Yankey said. The publication writes, "On efforts to fight malaria in the West African Sub-region, the Minister revealed that he is collaborating with his colleagues Ministers of Health in Nigeria, Cote D"Ivoire and others in the West African Sub-region to rid off the whole sub-region out of malaria." Yankey "called on pharmacists to be more active in the activities of the district health management team in their various areas," reports Ghanadot.com, which writes about other information addressed at the conference (Kunateh, 8/3). GNA/Homepage Ghana also reports on additional drug-related issues discussed at the conference (8/3). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):